INDOCO REMEDIES LIMITED

Location

Maharashtra

Founded

1947-08-23

Risk Signals

86 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about INDOCO REMEDIES LIMITED

Live alerts from global media, monitored by Business Radar

Is Indoco Remedies technically bullish or bearish?

2025-07-10 (marketsmojo.com)

Is Indoco Remedies technically bullish or bearish?

As of July 9, 2025, Indoco Remedies shows a neutral trend with mixed signals, as the weekly MACD is bullish while the RSI indicates bearish momentum, reflecting overall market indecision.

Read more
ACUTAAS CHEMICALS vs INDOCO REMEDIES - Comparison Results

2025-07-07 (equitymaster.com)

ACUTAAS CHEMICALS vs INDOCO REMEDIES - Comparison Results

Make stock comparison and analysis on (543349 | AMIORG~EQ) with Indoco Remedies (532612 | INDOCO~EQ) online at Equitymaster.

Read more
Indoco Remedies Ltd - Board of Directors |

2025-07-06 (capitalmarket.com)

Indoco Remedies Ltd - Board of Directors |

Indoco Remedies Ltd: Check Latest Board Directors of Indoco Remedies Ltd. View the list of Directors and designation of Indoco Remedies Ltd

Read more
Gufic BioSciences vs Indoco Remedies - which is better on financials, technicals, shareholding, share price target

2025-07-01 (trendlyne.com)

Gufic BioSciences vs Indoco Remedies - which is better on financials, technicals, shareholding, share price target

Compare Gufic BioSciences and Indoco Remedies on 41 parameters like - Sales, Sales growth, Profit, Profit growth, ROE, ROCE, Dividend yield etc

Read more
Why is Indoco Remedies falling/rising?

2025-06-30 (marketsmojo.com)

Why is Indoco Remedies falling/rising?

As of 30-Jun, Indoco Remedies Ltd's stock price has risen to Rs 320.50, reflecting a short-term gain of 5.08%. Despite recent performance improvements, the company faces significant long-term challenges, including a declining operating profit and consistent underperformance against benchmarks, raising concerns about its future stability.

Read more
Goa Leaders Slam Indoco Pharma for Advertising Jobs Outside State, Demand Immediate Withdrawal

2025-06-20 (heraldgoa.in)

Goa Leaders Slam Indoco Pharma for Advertising Jobs Outside State, Demand Immediate Withdrawal

Goa Leaders Slam Indoco Pharma for Advertising Jobs Outside State, Demand Immediate Withdrawal

Read more
INDOCO REMEDIES vs COHANCE LIFESCIENCES - Comparison Results

2025-06-18 (equitymaster.com)

INDOCO REMEDIES vs COHANCE LIFESCIENCES - Comparison Results

Make stock comparison and analysis on Indoco Remedies (532612 | INDOCO~EQ) with (543064 | SUVENPHAR~EQ) online at Equitymaster.

Read more
Indoco Remedies Ltd - 532612 - Announcement Under Regulation 30 (LODR):- Order For Drop Of Proceeding Under GST Act, 2017

2025-06-12 (trendlyne.com)

Indoco Remedies Ltd - 532612 - Announcement Under Regulation 30 (LODR):- Order For Drop Of Proceeding Under GST Act, 2017

Company Update

Read more
Initiative secures media mandate for Indoco Remedies' oral care brand Sensodent

2025-06-03 (socialsamosa.com)

Initiative secures media mandate for Indoco Remedies' oral care brand Sensodent

The agency will lead the brand's media strategy, planning, and deployment across platforms, focusing on driving awareness, trials, and brand relevance at scale.

Read more
Indoco Remedies Launches Ticagrelor 90mg Tablets in UK Through Clarity Pharma Distribution - GeneOnline News

2025-06-03 (geneonline.com)

Indoco Remedies Launches Ticagrelor 90mg Tablets in UK Through Clarity Pharma Distribution - GeneOnline News

Indoco Remedies has introduced Ticagrelor film-coated t […]

Read more
Indoco Remedies Reports Significant Financial Declines, Highlighting Operational Challenges in March 2025

2025-05-24 (marketsmojo.com)

Indoco Remedies Reports Significant Financial Declines, Highlighting Operational Challenges in March 2025

Indoco Remedies has reported challenging financial results for the quarter ending March 2025, with key metrics showing significant declines. The company recorded a negative operating profit margin, decreased net sales, and lower profit figures, indicating difficulties in operational efficiency and overall profitability.

Read more
Indoco Remedies receives USFDA final approval for Allopurinol Tablets |  News

2025-05-23 (capitalmarket.com)

Indoco Remedies receives USFDA final approval for Allopurinol Tablets | News

Indoco Remedies announced final approval of Allopurinol Tablets USP, 200 mg through Company's Abbreviated New Drug Application (ANDA) for Allopu...

Read more

Never miss a headline about INDOCO REMEDIES LIMITED

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages